CRL 1550
Latest Information Update: 29 Sep 2022
At a glance
- Originator CytRx Corporation
- Developer LadRx Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Spinal cord injuries
Most Recent Events
- 23 Sep 2022 CytRx Corporation is now called LadRx Corporation
- 15 Dec 2003 No development reported - Preclinical for Spinal cord injuries in USA (unspecified route)
- 19 Apr 2001 New profile